National Center for Advancing Translational Sciences; Notice of Closed Meeting, 50112 [2018-21567]
Download as PDF
<![CDATA[
50112
Federal Register / Vol. 83, No. 193 / Thursday, October 4, 2018 / Notices
daltland on DSKBBV9HB2PROD with NOTICES
the technical requirements for the
approval of pharmaceuticals for human
use in the ICH regions since 1990. More
information on the current ICH process
and structure can be found at the
following website: https://www.ich.org.
II. Participating in the Public Meeting
Registration: Persons interested in
attending this public meeting must
register online by October 12, 2018. To
register to attend the public meeting
either in person or via webcast, please
visit the following website: https://
www.eventbrite.ca/e/health-canada-usfda-ich-consultation-tickets47713713000. Please provide complete
contact information for each attendee,
including name, title, affiliation,
address, email, and telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public meeting must
register by October 12, 2018, 11:59 p.m.
Eastern Time. Early registration is
recommended because seating is
limited; therefore, the number of
participants from each organization may
be limited. The agenda for the public
meeting will be made available on the
internet at https://www.fda.gov/Drugs/
NewsEvents/ucm612657.htm
approximately 2 weeks in advance of
the meeting.
If you need special accommodations
due to a disability, please contact
William Lewallen (see FOR FURTHER
INFORMATION CONTACT) no later than
October 12, 2018.
Requests for Oral Presentations: If you
wish to make a presentation during the
public comment session, please contact
William Lewallen (see FOR FURTHER
INFORMATION CONTACT) no later than
October 12, 2018. Individuals and
organizations with common interests are
urged to consolidate or coordinate their
presentations and request time for a
joint presentation. All requests to make
presentations must be received by the
close of registration on October 12,
2018. If selected for presentation, any
presentation materials must be emailed
to William Lewallen (see FOR FURTHER
INFORMATION CONTACT) no later than
October 12, 2018. No commercial or
promotional material will be permitted
to be presented or distributed at the
public meeting.
Streaming Webcast of the Public
Meeting: This public meeting will also
be webcast. To register to attend via
webcast, please visit the following
website: https://www.eventbrite.ca/e/
health-canada-us-fda-ich-consultationtickets-47713713000. FDA has verified
the website addresses in this document,
as of the date this document publishes
VerDate Sep<11>2014
17:43 Oct 03, 2018
Jkt 247001
in the Federal Register, but websites are
subject to change over time.
Dated: September 28, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–21594 Filed 10–3–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative
Innovation Awards Review Meeting (U01).
Date: October 24, 2018.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 1068, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1073, Bethesda, MD
20892, 301–435–0810, lourdes.ponce@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: September 28, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–21567 Filed 10–3–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting Allergy, Immunology, and
Transplantation Research Committee.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Allergy, Immunology,
and Transplantation Research Committee
AITC January 2019 Council.
Date: October 23–24, 2018.
Time: 9:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer Scientific Review
Program, Division of Extramural Activities/
Room 3G31B, National Institutes of Health,
NIAID, 5601 Fishers Lane MSC 9834,
Bethesda, MD 20892–9834, (240) 669–5060,
james.snyder@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 28, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–21572 Filed 10–3–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 83, Number 193 (Thursday, October 4, 2018)]
[Notices]
[Page 50112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21567]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; CTSA Collaborative Innovation
Awards Review Meeting (U01).
Date: October 24, 2018.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, Room
1068, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences (NCATS), National Institutes of Health, 6701
Democracy Blvd., Democracy 1, Room 1073, Bethesda, MD 20892, 301-
435-0810, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: September 28, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-21567 Filed 10-3-18; 8:45 am]
BILLING CODE 4140-01-P
